USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-02-14 обновлены отчеты компании SONN: 2023-Q42023-Q32022-Q4
Sonnet BioTherapeutics Holdings logo
Sonnet BioTherapeutics Holdings SONN
$ 1.87 -2.6%

Sonnet BioTherapeutics Holdings Мультипликаторы 2011-2024 | SONN

Мультипликаторы по годам Sonnet BioTherapeutics Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.0 - -1.0 -0.8 -1.0 -1.4 -1.1 -0.8 -462.8 -872.9 -630.7 -

P/S

11.2 0.5 - - - 0.2 0.2 0.2 0.3 99.3 551.9 226673.6 -

EPS

-18.1 -150.5 -14.2 -7.0 -2.6 -2.0 -2.7 -4.2 -0.9 -0.9 -1.2 -1.2 -1.0

EV (Enterprise Value)

5.02 млн 5.51 млн -20.9 млн 22.8 млн 6.29 млн 28.6 млн 29 млн 29.8 млн 29.3 млн 2.98 млрд 4.56 млрд 734 млн 4.16 млн

EBITDA per Share

-18.1 -150 -14.3 -2.57 -22.9 -26.2 -31.4 -3.33 -67.5 -0.389 -0.783 -0.71 -

EV/EBITDA

0.8 -0.7 -0.8 -3.7 -4.4 -48.5 -2.6 -1204.2 -1332.0 -870.4 -1.2

PEG

-0.0 -0.0 - -0.01 -0.02 -0.04 -0.04 -0.02 0.0 -30.17 40.17 6.83 -

P/B

-7.4 -0.1 - 8.3 -1.4 0.9 0.9 0.7 0.5 197.9 405.0 132.6 -

P/CF

-0.1 -0.0 - 139.9 -1.8 -2.4 -4.2 -5.6 -1.4 -988.9 -715.4 -532.7 -

ROE %

8333.79 1170.74 -112.24 -803.50 171.19 -92.25 -63.46 -70.29 -56.80 -42.77 -46.39 -21.03 -208.24

ROA %

-346.86 -509.81 -86.17 -303.53 -12253.39 -23.01 -22.51 -27.11 -28.76 -17.89 -25.96 -15.21 -21.08

ROCE %

8316.05 1168.67 -112.70 -741.23 165.47 -32.02 -34.89 -12.26 -20.73 -22.74 -31.65 -16.27 -93.82

Current Ratio

1.0 0.7 4.3 1.6 0.0 0.1 0.1 0.1 0.2 0.1 0.3 1.1 0.2

DSO

- - - - - 3.9 4.2 4.6 9.6 3.4 10.1 18173.6 343.7

DIO

- - - - - 4.4 4.5 5.5 8.4 366.9 - - -

DPO

- - - - - - - - - 3843.1 - - -

Операционный цикл

- - - - - 8.2 8.7 10.1 18.0 370.3 - - -

Финансовый цикл

- - - - - 8.2 8.7 10.1 18.0 -3472.8 - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Sonnet BioTherapeutics Holdings

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.31 - -0.13 -0.34 -17.62 -0.37 -1.82 -1.91 -1.44 -0.93 -0.27 -0.32 -0.34 -2.23 -1.05 -0.34 -0.44 -0.39 -0.26 -13.28 - -0.34 -0.23 -0.83 - -0.7 -0.81 -0.79 - -0.41 -2.35 -0.07 - -0.31 -0.24 -0.27 - -0.52 -0.07 -0.24 - -0.38 -0.19 -0.2 - -0.2 -0.56 -0.28 - -0.4 -0.18 0.11

EBITDA per Share

-0.34 - - - -17.8 -4.02 -1.82 -1.91 -1.44 -0.93 -0.28 -0.32 -0.34 -2.23 -1.04 -0.32 -0.44 -0.37 -0.16 -8.63 - -0.04 0.03 -0.58 - -0.33 -0.2 -0.18 - 0.03 0.03 -0.02 - -0.05 -0.11 -0.23 - -0.01 -0.02 -0.26 - -0.16 -0.12 -0.18 - -0.13 -0.31 -0.17 - -0.22 -0.18 0.11

ROE %

-381.89 -64.33 813.53 -101.76 -92.40 -286.91 -1245.78 -661.87 -864.30 -590.17 -272.87 410.26 945.17 811.78 662.26 402.42 173.99 67.16 -36.27 -22.96 -65.78 -77.83 -77.15 -85.10 -50.29 -57.49 -48.71 -70.74 -58.76 -79.52 -93.08 -69.21 -47.53 -51.21 -34.13 -21.33 -16.85 -32.32 -44.10 -46.84 -28.32 -41.70 -39.62 -48.59 -41.37 -143.43 -232.10 -263.36 -102.11 -102.06 -46.52 46.46

ROA %

-143.13 -194.03 -576.30 -642.14 -654.12 -571.90 -251.82 -231.87 -198.14 -362.03 -373.35 -361.64 -414.33 -228.38 -6365.70 -6295.30 -6222.37 -6215.52 -8.84 -8.28 -16.41 -21.09 -22.61 -26.50 -17.84 -20.54 -17.57 -26.21 -22.05 -32.75 -40.75 -34.09 -24.50 -26.04 -16.88 -10.00 -7.13 -14.22 -19.77 -21.74 -14.28 -23.95 -26.54 -34.06 -29.91 -40.24 -40.90 -34.58 -10.34 -10.33 -4.71 4.70

ROCE %

-384.30 -61.38 816.71 -98.22 -88.92 -285.50 -1245.09 -671.52 -873.83 -600.15 154.63 1083.59 1617.88 1485.01 960.50 464.09 275.31 163.37 5.56 23.25 -46.73 -59.79 -63.82 -68.27 -32.40 -36.52 -27.58 -21.60 -15.45 -20.43 -21.29 -24.46 -21.02 -24.57 -23.14 -19.27 -17.49 -28.09 -35.15 -37.84 -23.62 -37.39 -40.56 -45.89 -34.43 -93.34 -138.48 -174.26 -62.03 -58.91 -47.23 44.12

Current Ratio

1.9 1.0 1.5 1.7 0.6 0.7 1.1 2.3 4.8 4.3 1.2 4.3 0.6 1.6 1.6 1.6 0.9 0.0 1.2 1.2 1.4 1.4 1.4 1.4 1.6 1.6 1.6 1.6 1.7 1.7 1.7 1.7 2.1 2.1 2.1 2.1 1.7 1.7 1.7 1.7 2.3 2.3 2.3 2.3 3.6 3.6 3.6 3.6 1.1 1.1 1.1 1.1

DSO

- - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

Финансовый цикл

- - - - - - - - - - - - - - - 1.6 - 3.5 4.4 4.1 - 3.4 3.4 3.9 - 4.0 4.0 4.6 - 4.4 4.5 6.3 - 8.5 9.3 6.3 - 3.1 4.4 4.6 - 12.9 12.4 10.6 - 8.5 8.5 8.7 - -1694.8 289.0 -

Все данные представлены в валюте USD